Identification of CLIC3 as a novel prognostic biomarker in triple-negative breast cancer via characteristic analysis
RNA-seq (gene expression) · human · 32 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 32 samples: 32 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- CLIC3 emerges as a novel prognostic biomarker and therapeutic target in triple-negative breast cancer through integrated multi-omics analysisBMC cancer · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE267444_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1111516 and SRA study SRP507611. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 32 sample titles: 32 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8266835 428258_N
- GSM8266836 428258_T
- GSM8266837 429752_N
- GSM8266838 429752_T
- GSM8266839 430223_N
- GSM8266840 430223_T
- GSM8266841 430299_N
- GSM8266842 430299_T
- GSM8266843 431003_N
- GSM8266844 431003_T
- GSM8266845 440601_N
- GSM8266846 440601_T
- GSM8266847 440634_N
- GSM8266848 440634_T
- GSM8266849 440796_N
- GSM8266850 440796_T
- GSM8266851 8_428258-N WES
- GSM8266852 8_428258-T WES
- GSM8266853 6_429752-N WES
- GSM8266854 6_429752-T WES
- GSM8266855 10_430223-N WES
- GSM8266856 10_430223-T WES
- GSM8266857 11_430299-N WES
- GSM8266858 11_430299-T WES
- GSM8266859 12_431003-N WES
- GSM8266860 12_431003-T WES
- GSM8266861 4_440601-N WES
- GSM8266862 4_440601-T WES
- GSM8266863 3_440634-N WES
- GSM8266864 3_440634-T WES
- GSM8266865 5_440796-N WES
- GSM8266866 5_440796-T WES
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares prognostic, breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE267442 Identification of CLIC3 as a novel prognostic biomarker in triple-negative breast cancer via characteristic analysis (RNA-Seq) 16 samples shares clic3, triple-negative, characteristic, prognostic, biomarker, breast
- GSE300385 Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies 12 samples shares triple-negative, biomarker, breast
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples shares prognostic, biomarker, breast
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.